Skip to main content
Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
114.00
0.00 (0.00%)
Apr 28, 2026, 3:48 PM IDT

TLV:IMED Revenue

In the year 2025, Imed Infinity Medical-Limited Partnership had annual revenue of $226.00K USD with 451.22% growth. Imed Infinity Medical-Limited Partnership had revenue of $-431.00K in the half year ending December 31, 2025, with 14.93% growth.

Revenue
$226.00K
Revenue Growth
+451.22%
P/S Ratio
6.38
Revenue / Employee
$2.83K
Employees
80
Market Cap
4.60M ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025226.00K185.00K451.22%
Dec 31, 202441.00K983.00K-104.35%
Dec 31, 2023-942.00K-1.14M-571.00%
Dec 31, 2022200.00K125.00K166.67%
Dec 31, 202175.00K--
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 55.02B
Danel (Adir Yeoshua) 2.90B
Amal Holdings A.D. 2.18B
BrainsWay 166.49M
Bio-View 19.93M
Can-Fite BioPharma 1.29M
Erika Carmel-Tech 37.34M
XTL Biopharmaceuticals 3.26M
Revenue Rankings